Google’s new service is a game-changer and the chipmaker it chose to power the platform’s graphics might surprise you.
Read MoreAnd the sector may have good news for the broader market. Here’s why.
Read MoreThe hedge fund—which returned a whopping 41% last year—has a warning for investors.
Read MoreThese two analysts are bullish on the yoga pants maker and see double-digit upside ahead this year.
Read MoreThe semiconductor industry is consistently one of the most interesting segments of the market to pay attention to; it seems to be a benchmark for the rest of the tech sector, and over the past few years has unquestionably lead the market from the standpoint of momentum and performance, to both the upside and downside. […]
Read MoreAeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology, endocrinology, and women’s health. Its commercial product is the Macrilen, a ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a, a ghrelin receptor, which is used for endocrinology and oncology indications. The […]
Read MoreShares of Viacom Inc. (VIAB) led the S&P 500’s list of losers on Wednesday after the media conglomerate – which owns hundreds of film and TV assets like Paramount Pictures, MTV, and Nickelodeon – announced a troubling dispute with another American media giant. Even if investors don’t include today’s loss, Viacom has been on a […]
Read More